4.7 Article

Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS

Journal

NEUROBIOLOGY OF DISEASE
Volume 142, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2020.104935

Keywords

Amyotrophic lateral sclerosis (ALS); Motor neuron; Neuromuscular junction; Zebrafish; FUS; Tau Frontotemporal dementia; Genetics; Neurodegeneration

Categories

Funding

  1. ANR program (project ToFU)
  2. ERC Consolidator Program (project ALS-Networkds)
  3. AFM-Telethon
  4. ARSLA
  5. IHU-Imagine program of excellence

Ask authors/readers for more resources

Mutations in Fused in sarcoma (FUS), an RNA-binding protein, are known to cause Amyotrophic Lateral Sclerosis (ALS). However, molecular mechanisms due to loss of FUS function remain unclear and controversial. Here, we report the characterization and phenotypic analysis of a deletion mutant of the unique FUS orthologue in zebrafish where Fus protein levels are depleted. The homozygous mutants displayed a reduced lifespan as well as impaired motor abilities associated with specific cellular deficits, including decreased motor neurons length and neuromuscular junctions (NMJ) fragmentation. Furthermore, we demonstrate that these cellular impairments are linked to the misregulation of mRNA expression of acetylcholine receptor (AChR) subunits and histone deacetylase 4, markers of denervation and reinnervation processes observed in ALS patients. In addition, fus loss of function alters tau transcripts favoring the expression of small tau isoforms. Overall, this new animal model extends our knowledge on FUS and supports the relevance of FUS loss of function in ALS physiopathology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

ALSUntangled No. 36: Accilion

Richard Bedlack, Emma Fixsen, Colin Quinn, Chafic Karam, Alex Sherman, Lyle Ostrow, Orla Hardiman, Terry Heiman-Patterson, Laurie Gutmann, Mark Bromberg, Gregory Carter, Edor Kabashi, Tulio Bertorini, Tahseen Mozaffar, Peter Andersen, Josep Gamez, Mazen Dimachkie, Yunxia Wang, Paul Wicks, James Heywood, Steven Novella, L. P. Rowland, Erik Pioro, Lisa Kinsley, Kathy Mitchell, Jonathan Glass, Sith Sathornsumetee, Jon Baker, Nazem Atassi, Dallas Forshew, John Ravits, Robin Conwit, Carlayne Jackson, Kate Dalton, Katherine Tindall, Ginna Gonzalez, Janice Robertson, Larry Phillips, Michael Benatar, Eric Sorenson, Christen Shoesmith, Steven Nash, Nicholas Maragakis, Dan Moore, James Caress, Kevin Boylan, Carmel Armon, Megan Grosso, Bonnie Gerecke, Jim Wymer, Bjorn Oskarsson, Robert Bowser, Vivian Drory, Jeremy Shefner, Noah Lechtzin, Melanie Leitner, Robert Miller, Todd Levine, James Russell, Khema Sharma, David Saperstein, Leo McClusky, Daniel MacGowan, Jonathan Licht, Ashok Verma, Michael Strong, Catherine Lomen-Hoerth, Rup Tandan, Michael Rivner, Steve Kolb, Meraida Polak, Stacy Rudnicki, Pamela Kittrell, Muddasir Quereshi, George Sachs, Gary Pattee, Michael Weiss, John Kissel, Jonathan Goldstein, Jeffrey Rothstein, Dan Pastula, Gleb Levitsky, Mieko Ogino, Jeffrey Rosenfeld, Efrat Carmi, Christina Fournier, Paul Barkhaus, Brett Morrison, Lome Zinman, Eric Valor, Neta Zach, Ahmad Ghavanini, Yvonne Baker, Kristiana Salmon, Steve Perrin, Rob Goldstein, Fernando Vieira, Merit Cudkowicz, Hiroshi Mitsumoto

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)

Article Clinical Neurology

ALSUntangled No. 37: Inosine

Sabrina Paganoni, Richard Bedlack, Emma Fixsen, Colin Quinn, Chafic Karam, Alex Sherman, Lyle Ostrow, Orla Hardiman, Terry Heiman-Patterson, Laurie Gutmann, Mark Bromberg, Gregory Carter, Edor Kabashi, Tulio Bertorini, Tahseen Mozaffar, Peter Andersen, Josep Gamez, Mazen Dimachkie, Yunxia Wang, Paul Wicks, James Heywood, Steven Novella, L. P. Rowland, Erik Pioro, Lisa Kinsley, Kathy Mitchell, Jonathan Glass, Sith Sathornsumetee, Jon Baker, Nazem Atassi, Dallas Forshew, John Ravits, Robin Conwit, Carlayne Jackson, Kate Dalton, Katherine Tindall, Ginna Gonzalez, Janice Robertson, Larry Phillips, Michael Benatar, Eric Sorenson, Christen Shoesmith, Steven Nash, Nicholas Maragakis, Dan Moore, James Caress, Kevin Boylan, Carmel Armon, Megan Grosso, Bonnie Gerecke, Jim Wymer, Bjorn Oskarsson, Robert Bowser, Vivian Drory, Jeremy Shefner, Noah Lechtzin, Melanie Leitner, Robert Miller, Todd Levine, James Russell, Khema Sharma, David Saperstein, Leo McClusky, Daniel MacGowan, Jonathan Licht, Ashok Verma, Michael Strong, Catherine Lomen-Hoerth, Rup Tandan, Michael Rivner, Steve Kolb, Meraida Polak, Stacy Rudnicki, Pamela Kittrell, Muddasir Quereshi, George Sachs, Gary Pattee, Michael Weiss, John Kissel, Jonathan Goldstein, Jeffrey Rothstein, Dan Pastula, Gleb Levitsky, Mieko Ogino, Jeffrey Rosenfeld, Efrat Carmi, Christina Fournier, Paul Barkhaus, Brett Morrison, Lorne Zinman, Eric Valor, Neta Zach, Ahmad Ghavanini, Yvonne Baker, Kristiana Salmon, Steve Perrin, Rob Goldstein, Fernando Vieira, Merit Cudkowicz, Hiroshi Mitsumoto, Keelie Denson, Ceri Weber

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)

Article Clinical Neurology

ALS Untangled No.33 Endotherapia

Richard Bedlack, Colin Quinn, Chafic Karam, Alex Sherman, Lyle Ostrow, Orla Hardiman, Terry Heiman-Patterson, Laurie Gutmann, Mark Bromberg, Gregory Carter, Edor Kabashi, Tulio Bertorini, Tahseen Mozaffar, Peter Andersen, Jeff Dietz, Josep Gamez, Mazen Dimachkie, Yunxia Wang, Paul Wicks, James Heywood, Steven Novella, L. P. Rowland, Erik Pioro, Lisa Kinsley, Kathy Mitchell, Jonathan Glass, Sith Sathornsumetee, Jon Baker, Nazem Atassi, Dallas Forshew, John Ravits, Robin Conwit, Carlayne Jackson, Kate Dalton, Katherine Tindall, Ginna Gonzalez, Janice Robertson, Larry Phillips, Michael Benatar, Eric Sorenson, Christen Shoesmith, Steven Nash, Nicholas Maragakis, Dan Moore, James Caress, Kevin Boylan, Carmel Armon, Megan Grosso, Bonnie Gerecke, Jim Wymer, Bjorn Oskarsson, Robert Bowser, Vivian Drory, Jeremy Shefner, Noah Lechtzin, Melanie Leitner, Robert Miller, Hiroshi Mitsumoto, Todd Levine, James Russell, Khema Sharma, David Saperstein, Leo McClusky, Daniel MacGowan, Jonathan Licht, Ashok Verma, Michael Strong, Catherine Lomen-Hoerth, Rup Tandan, Michael Rivner, Steve Kolb, Meraida Polak, Stacy Rudnicki, Pamela Kittrell, Muddasir Quereshi, George Sachs, Gary Pattee, Michael Weiss, John Kissel, Jonathan Goldstein, Jeffrey Rothstein, Dan Pastula, Gleb Levitsky, Mieko Ogino, Jeffrey Rosenfeld, Efrat Carmi, Merit Cudkowicz, Christina Fournier, Paul Barkhaus, Brett Morrison, Lorne Zinman, Craig Oster, Eric Valor, Neta Zach, Ahmad Ghavanini, Yvonne Baker, Kristiana Salmon

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)

Article Clinical Neurology

ALSUntangled 38: L-serine THE ALSUNTANGLED GROUP

Veronica Peschansky, Richard Bedlack, Colin Quinn, Chafic Karam, Alex Sherman, Lyle Ostrow, Orla Hardiman, Terry Heiman-Patterson, Laurie Gutmann, Mark Bromberg, Gregory Carter, Edor Kabashi, Tulio Bertorini, Tahseen Mozaffar, Peter Andersen, Josep Gamez, Mazen Dimachkie, Yunxia Wang, Paul Wicks, James Heywood, Steven Novella, L. P. Rowland, Erik Pioro, Lisa Kinsley, Kathy Mitchell, Jonathan Glass, Sith Sathornsumetee, Jon Baker, Nazem Atassi, Dallas Forshew, John Ravits, Robin Conwit, Carlayne Jackson, Kate Dalton, Katherine Tindall, Ginna Gonzalez, Janice Robertson, Larry Phillips, Michael Benatar, Eric Sorenson, Christen Shoesmith, Steven Nash, Nicholas Maragakis, Dan Moore, James Caress, Kevin Boylan, Carmel Armon, Megan Grosso, Bonnie Gerecke, Jim Wymer, Bjorn Oskarsson, Robert Bowser, Vivian Drory, Jeremy Shefner, Noah Lechtzin, Melanie Leitner, Robert Miller, Todd Levine, James Russell, Khema Sharma, David Saperstein, Leo McClusky, Daniel MacGowan, Jonathan Licht, Ashok Verma, Michael Strong, Catherine Lomen-Hoerth, Rup Tandan, Michael Rivner, Steve Kolb, Meraida Polak, Stacy Rudnicki, Pamela Kittrell, Muddasir Quereshi, George Sachs, Gary Pattee, Michael Weiss, John Kissel, Jonathan Goldstein, Jeffrey Rothstein, Dan Pastula, Gleb Levitsky, Mieko Ogino, Jeffrey Rosenfeld, Efrat Carmi, Christina Fournier, Paul Barkhaus, Brett Morrison, Lorne Zinman, Eric Valour, Neta Zach, Ahmad Ghavanini, Yvonne Baker, Kristiana Salmon, Steve Perrin, Rob Goldstein, Fernando Vieira, Merit Cudkowicz, Hiroshi Mitsumoto, Emma Fixen, Ceri Weber, Keeli Hope Denson

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)

Article Geriatrics & Gerontology

ATXN2 trinucleotide repeat length correlates with risk of ALS

William Sproviero, Aleksey Shatunov, Daniel Stahl, Maryam Shoai, Wouter van Rheenen, Ashley R. Jones, Safa Al-Sarraj, Peter M. Andersen, Nancy M. Bonini, Francesca L. Conforti, Philip Van Damme, Hussein Daoud, Maria Del Mar Amador, Isabella Fogh, Monica Forzan, Ben Gaastra, Cinzia Gellera, Aaron D. Gitler, John Hardy, Pietro Fratta, Vincenzo La Bella, Isabelle Le Ber, Tim Van Langenhove, Serena Lattante, Yi-Chung Lee, Andrea Malaspina, Vincent Meininger, Stephanie Millecamps, Richard Orrell, Rosa Rademakers, Wim Robberecht, Guy Rouleau, Owen A. Ross, Francois Salachas, Katie Sidle, Bradley N. Smith, Bing-Wen Soong, Gianni Soraru, Giovanni Stevanin, Edor Kabashi, Claire Troakes, Christine van Broeckhoven, Jan H. Veldink, Leonard H. van den Berg, Christopher E. Shaw, John F. Powell, Ammar Al-Chalabi

NEUROBIOLOGY OF AGING (2017)

Article Clinical Neurology

Depdc5 knockdown causes mTOR-dependent motor hyperactivity in zebrafish

Hortense de Calbiac, Adriana Dabacan, Elise Marsan, Herve Tostivint, Gabrielle Devienne, Saeko Ishida, Eric Leguern, Stephanie Baulac, Raul C. Muresan, Edor Kabashi, Sorana Ciura

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Article Neurosciences

Transcriptomic Analysis of Zebrafish TDP-43 Transgenic Lines

Alexandra Lissouba, Meijiang Liao, Edor Kabashi, Pierre Drapeau

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Review Clinical Neurology

Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis

Maria-Letizia Campanari, Annis-Rayan Bourefis, Edor Kabashi

FRONTIERS IN NEUROLOGY (2019)

Article Cell Biology

Functional Characterization of Neurofilament Light Splicing and Misbalance in Zebrafish

Doris Lou Demy, Maria Letizia Campanari, Raphael Munoz-Ruiz, Heather D. Durham, Benoit J. Gentil, Edor Kabashi

CELLS (2020)

Article Cell Biology

TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish

Maria-Letizia Campanari, Anca Marian, Sorana Ciura, Edor Kabashi

Summary: The study suggests that AChE plays a crucial role in ALS pathology by regulating NMJ function. Knockdown of TDP-43 in zebrafish led to NMJ dysfunction, which was partially rescued by overexpression of human AChE. This finding provides insights into the early defects in NMJs in ALS and highlights AChE as a potential therapeutic target for the disease.

CELLS (2021)

Review Cell Biology

Autophagy and ALS: mechanistic insights and therapeutic implications

Jason P. Chua, Hortense De Calbiac, Edor Kabashi, Sami J. Barmada

Summary: Protein homeostasis mechanisms are crucial for maintaining the health of neurons and other cells in the central nervous system, while autophagy plays a key role in preventing and combating pathogenic insults that may lead to neurodegenerative diseases. However, the specific mechanisms underlying the neuroprotective role of autophagy, neuronal resistance to autophagy induction, and the effects of autophagy-impairing mutations on neurons are not fully understood. Additionally, the contribution of non-cell autonomous effects of autophagy dysfunction to ALS pathogenesis remains incompletely defined.

AUTOPHAGY (2022)

Article Multidisciplinary Sciences

Freezing activity brief data from a new FUS mutant zebrafish line

Maria-Letizia Campanari, Annis-Rayan Bourefis, Valerie Buee-Scherrer, Edor Kabashi

DATA IN BRIEF (2020)

Article Clinical Neurology

Association of Rare Genetic Variants in Opioid Receptors with Tourette Syndrome

Christel Depienne, Sorana Ciura, Oriane Trouillard, Delphine Bouteiller, Elsa Leitao, Caroline Nava, Boris Keren, Yannick Marie, Justine Guegan, Sylvie Forlani, Alexis Brice, Mathieu Anheim, Yves Agid, Paul Krack, Philippe Damier, Francois Viallet, Jean-Luc Houeto, Franck Durif, Marie Vidailhet, Yulia Worbe, Emmanuel Roze, Edor Kabashi, Andreas Hartmann

TREMOR AND OTHER HYPERKINETIC MOVEMENTS (2019)

Article Medicine, Research & Experimental

Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis

Shunmoogum A. Patten, Dina Aggad, Jose Martinez, Elsa Tremblay, Janet Petrillo, Gary A. B. Armstrong, Alexandre La Fontaine, Claudia Maios, Meijiang Liao, Sorana Ciura, Xiao-Yan Wen, Victor Rafuse, Justin Ichida, Lorne Zinman, Jean-Pierre Julien, Edor Kabashi, Richard Robitaille, Lawrence Korngut, J. Alexander Parker, Pierre Drapeau

JCI INSIGHT (2017)

Article Neurosciences

Cell-type brain-region specific changes in prefrontal cortex of a mouse model of alcohol dependence

Nihal A. Salem, Lawrence Manzano, Michael W. Keist, Olga Ponomareva, Amanda J. Roberts, Marisa Roberto, R. Dayne Mayfield

Summary: This study identified cell-type specific gene expression changes associated with alcohol dependence in the medial prefrontal cortex of mice. The results revealed dysregulated gene co-expression networks and differentially expressed genes in multiple cell types, highlighting the involvement of inhibitory neurons and astrocytes in alcohol dependence. Novel targets for studying molecular mechanisms contributing to alcohol dependence were also identified.

NEUROBIOLOGY OF DISEASE (2024)

Article Neurosciences

Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model

Laura E. Hawley, Megan Stringer, Abigail J. Deal, Andrew Folz, Charles R. Goodlett, Randall J. Roper

Summary: This study found that the overexpression of DYRK1A protein in Down syndrome mice varies with age, sex, and brain region, and reducing the copy number of Dyrk1a can decrease the expression of DYRK1A. These sex-specific patterns of DYRK1A overexpression may provide mechanistic targets for therapeutic intervention in Down syndrome.

NEUROBIOLOGY OF DISEASE (2024)